Get the Stockscreener App
1.05
0.00%
0.00
Pre-market:
1.05
Enlivex Therapeutics Ltd stock is traded at $1.05, with a volume of 66,179.
It is up +0.00% in the last 24 hours and up +0.96% over the past month.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
See More
Previous Close:
$1.05
Open:
$1.05
24h Volume:
66,179
Relative Volume:
0.13
Market Cap:
$24.83M
Revenue:
-
Net Income/Loss:
$-14.33M
P/E Ratio:
-1.5909
EPS:
-0.66
Net Cash Flow:
$-13.21M
1W Performance:
-1.41%
1M Performance:
+0.96%
6M Performance:
+2.94%
1Y Performance:
-22.22%
1-Day Range:
$1.0286
$1.0686
1-Week Range:
$1.0286
$1.16
52-Week Range:
$0.8101
$2.10
Enlivex Therapeutics Ltd Stock (ENLV) Company Profile
Name
Enlivex Therapeutics Ltd
Sector
Industry
Phone
-
Address
-
Compare ENLV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENLV
Enlivex Therapeutics Ltd
|
1.05 | 25.51M | 0 | -14.33M | -13.21M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Enlivex Therapeutics Ltd Stock (ENLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-02-21 | Reiterated | H.C. Wainwright | Buy |
Enlivex Therapeutics Ltd Stock (ENLV) Latest News
How Enlivex Therapeutics Ltd. stock reacts to job market dataQuarterly Profit Review & Safe Investment Capital Preservation Plans - newser.com
Will Enlivex Therapeutics Ltd. stock gain from strong economy2025 Top Gainers & High Yield Stock Recommendations - newser.com
Will Enlivex Therapeutics Ltd. stock maintain dividend yield2025 Price Targets & Smart Swing Trading Techniques - newser.com
Can Enlivex Therapeutics Ltd. stock maintain operating marginsMarket Sentiment Review & Entry Point Confirmation Signals - newser.com
What’s the recovery path for long term holders of Enlivex Therapeutics Ltd.GDP Growth & Technical Entry and Exit Alerts - newser.com
Price action breakdown for Enlivex Therapeutics Ltd.Earnings Beat & Safe Entry Zone Identification - newser.com
Comparing Enlivex Therapeutics Ltd. in custom built stock radarsJuly 2025 Reactions & Intraday High Probability Setup Alerts - newser.com
Technical signs of recovery in Enlivex Therapeutics Ltd.2025 Trade Ideas & Fast Gain Stock Tips - newser.com
Why analysts remain bullish on Enlivex Therapeutics Ltd. stock2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pocono Record
Why Enlivex Therapeutics Ltd. stock is considered a top pickWatch List & Real-Time Buy Signal Alerts - newser.com
Backtesting results for Enlivex Therapeutics Ltd. trading strategiesDollar Strength & AI Optimized Trade Strategies - newser.com
Trend analysis for Enlivex Therapeutics Ltd. this weekTrade Exit Summary & Community Consensus Trade Signals - newser.com
Has Enlivex Therapeutics Ltd. found a price floorTrade Entry Summary & Community Verified Watchlist Alerts - newser.com
Can Enlivex Therapeutics Ltd. stock deliver consistent earnings growthQuarterly Performance Summary & Technical Pattern Based Signals - newser.com
Will Enlivex Therapeutics Ltd. stock deliver shareholder valueQuarterly Trade Report & High Accuracy Swing Trade Signals - newser.com
How to recover losses in Enlivex Therapeutics Ltd. stock2025 Retail Activity & Weekly High Momentum Picks - newser.com
Published on: 2025-10-31 00:58:35 - newser.com
Published on: 2025-10-30 23:36:56 - newser.com
Using portfolio simulators with Enlivex Therapeutics Ltd. includedEarnings Recap Summary & AI Enhanced Execution Alerts - newser.com
Enlivex Therapeutics Ltd Stock (ENLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):